Hitachi Announces Strategic Partnership With Anthropic to Strengthen "Lumada 3.0" Through Frontier AI
19.5.2026 02:00:00 CEST | Business Wire | Press Release
Hitachi, Ltd. (TSE:6501, "Hitachi") today announced a strategic partnership with Anthropic PBC (“Anthropic”), a global leader in AI safety research and trusted AI models, to further strengthen the “Lumada 3.0” business model.
As artificial intelligence evolves beyond cyberspace to directly influence real-world systems—otherwise known as physical AI—demand is rapidly growing for the safe and seamless deployment of AI in mission-critical environments.
This alliance will combine Hitachi’s deep domain knowledge built over more than 110 years, along with its expertise in IT, OT (operational technology), and products, with Anthropic’s frontier AI capabilities. Together, the companies will accelerate the advancement of system engineering, operations, and cybersecurity for critical infrastructure sectors including energy, transportation, manufacturing, and finance. By enabling safer, more resilient, and intelligent operations of these infrastructures, the partnership will contribute to advancing AI transformation (AX) for customers and society at large.
To maximize value creation for customers, Hitachi and Anthropic will also drive transformation within Hitachi’s own organizations. Hitachi will deploy advanced AI, including Anthropic’s Claude models, across all business processes for its approximately 290,000 employees worldwide to significantly enhance productivity. In parallel, the two companies will jointly develop and implement talent programs to cultivate approximately 100,000 AI professional talent. Hitachi positions this large-scale internal transformation as “Customer Zero,” leveraging the insights and best practices gained to further advance HMAX by Hitachi—a next-generation suite of solutions that brings the power of AI to social infrastructure.
As the core engine to drive value creation for customers in over 190 countries and to advance its own transformation globally, Hitachi will establish the “Frontier AI Deployment Center,” a global organization spanning North America, Europe, and Asia. As its initial initiative, the Center will launch a joint team comprising Anthropic’s Applied AI experts and Hitachi’s specialists across IT, OT, products, and cybersecurity, bringing together the strengths and expertise of both companies.
Going forward, Hitachi will leverage this Center as a foundation to establish best practices for enterprise-scale deployment, accelerate value creation at customers’ frontlines, and contribute to the realization of a harmonized society through the safe and scalable implementation of frontier AI.
Background
Artificial intelligence is rapidly evolving from a tool confined to digital domains into technologies that directly interact with and control real-world systems. This shift toward physical AI creates unprecedented opportunities to address pressing societal challenges, including labor shortages and increasing burdens on frontline workers in industries such as manufacturing, maintenance, and infrastructure operations.
As a global leader in social innovation, Hitachi recognizes this transition as a significant mission. Hitachi is advancing its “Lumada 3.0” business model, which integrates data from globally deployed IT, OT, and products with deep domain knowledge and AI to solve societal challenges. However, as AI becomes deeply embedded in real-world infrastructure and operations, exceptional levels of safety, reliability, and trust are essential. Through this strategic partnership with Anthropic—provider of the advanced AI model Claude, which meets these requirements and has a strong track record in the enterprise domain—Hitachi will further strengthen its HMAX solutions, which embody its Lumada 3.0 business model and accelerate the empowerment of frontline workers.
Strategic Initiatives
1. Accelerating AX through the Integration of Anthropic’s Claude and Hitachi’s Capabilities
By combining the advanced code generation and analysis capabilities of Anthropic’s Claude with Hitachi’s system engineering expertise in mission-critical domains, the partnership will deliver significant improvements in efficiency and quality across customers’ system development and operations. This will strongly support customers’ AX, enabling the rapid launch of new services and the advancement of data-driven business transformation in fast-changing market environments. Additionally, the partnership will enhance cybersecurity for critical infrastructure sectors such as finance, transportation, and power transmission and distribution. Through close collaboration between Hitachi’s Cyber Center of Excellence and Anthropic, the companies will advance capabilities in cyber threat detection and response, fundamentally strengthening the cyber resilience of social infrastructure and providing a robust environment for the safe and secure deployment of AI.
2. Enterprise-wide Transformation at Hitachi
Hitachi aims to become one of the world’s largest enterprise adopters of Claude, deploying advanced AI across all business processes for approximately 290,000 employees.
This includes:
- Reducing development effort in software engineering
- Enhancing efficiency in corporate functions
- Automating maintenance and operational processes in hardware environments
By extending AI adoption beyond engineers to business functions such as sales and planning, Hitachi will accelerate enterprise-wide transformation. In parallel, a large-scale talent development program will be launched to enable approximately 100,000 employees to become AI professional talent embedded in daily operations. Insights gained from this “Customer Zero” initiative will be continuously fed back into customer offerings.
3. Advancing HMAX through frontier AI
By combining its OT and product expertise with advanced AI, Hitachi will further enhance HMAX solutions. Claude’s high-level reasoning capabilities will be integrated into HMAX to expand AI applications in mission-critical environments. This includes enhancing:
- Intuitive equipment management through natural language interaction to minimize downtime
- Optimization of maintenance operations through advanced algorithms to reduce costs
These capabilities will directly contribute to greater resilience and sustainability for customer operations and infrastructure.
4. Accelerating Value Creation through the Frontier AI Deployment Center
The Frontier AI Deployment Center will serve as the core of Hitachi’s AI collaboration ecosystem. Beginning with a joint team of approximately 100 experts—expected to scale to 300 over time—this organization will drive:
- Co-creation of physical AI use cases
- Deployment of advanced AI technologies in real-world settings
- Development of next-generation solutions
Comment from Jun Abe, Executive Vice President, Head of Digital Systems & Services Sector, Hitachi
“Through our Social Innovation Business, Hitachi has long contributed to the realization of a sustainable society. Today, as challenges facing frontline workers become more pronounced due to a shrinking workforce, we are very pleased that through this strategic partnership, Hitachi can jointly solve customer and social challenges by combining Anthropic’s highly trusted AI technology with Hitachi’s domain expertise in mission-critical areas and our IT, OT, and product capabilities. As a global leader continuing to innovate social infrastructure with digital technologies, and by leveraging advanced AI ourselves as a practitioner, we will accelerate transformation at our customers' frontlines and promote true Digital Transformation in the real world, striving together to realize a harmonized society.”
About HMAX & Lumada
Trademark Notice: All trademarks and product names are the property of their respective owners.
About Hitachi, Ltd.
Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi aims to be a global leader in continuously transforming social infrastructure through digital, contributing to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates worldwide across four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – as well as a Strategic SIB Business Unit focused on new growth areas. With Lumada at its core, Hitachi creates value by combining data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2025 (ended March 31, 2026) totaled 10,586.7 billion yen, with 606 consolidated subsidiaries and approximately 290,000 employees worldwide. Visit us at www.hitachi.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260518301548/en/
Contacts
Media Contact
Heather Ailara
PR Manager
Hitachi, Ltd
heather@211comms.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom